Professor Zhao Xingquan: Brain Hemorrhage and Vascular Neurology Expert in Beijing

Professor Zhao Xingquan: Brain Hemorrhage and Vascular Neurology Expert in Beijing

Professor Zhao Xingquan: Intracerebral Hemorrhage and Neurocritical Care Specialist

Professor Zhao Xingquan is a senior neurologist, professor, doctoral supervisor, director of the Neurology Center and head of Vascular Neurology at Beijing Tiantan Hospital. His clinical and academic work focuses on intracerebral hemorrhage, ischemic stroke, dizziness and neuro-otology, neurocritical care, and standardized evaluation of complex cerebrovascular disease.

Clinical and Academic Focus

  • spontaneous intracerebral hemorrhage;
  • acute ischemic stroke and TIA;
  • secondary stroke prevention;
  • neurocritical care;
  • dizziness, vertigo, and neuro-otology;
  • posterior-circulation stroke;
  • stroke-related inflammation and prognosis;
  • complex antithrombotic decisions; and
  • second opinions after severe stroke.

Intracerebral Hemorrhage

Intracerebral hemorrhage occurs when a blood vessel ruptures and bleeds into brain tissue. Symptoms may include sudden weakness, speech difficulty, vomiting, severe headache, reduced consciousness, imbalance, or seizure.

Emergency management can include blood-pressure control, reversal of anticoagulation, airway and intensive care, treatment of increased intracranial pressure, seizure management, and surgery in selected patients.

Professor Zhao has led work on precise assessment and standardized management of brain hemorrhage, including research on inflammatory biomarkers and clinical outcomes.

Finding the Cause of Brain Hemorrhage

Common causes include chronic hypertension, cerebral amyloid angiopathy, anticoagulant treatment, vascular malformations, aneurysm, tumor, venous thrombosis, and clotting disorders.

Evaluation may require CT angiography, MRI, catheter angiography, medication review, and laboratory testing. Identifying the cause is essential for preventing another hemorrhage.

Ischemic Stroke and TIA

Ischemic stroke results from blocked blood flow, while a transient ischemic attack causes temporary stroke-like symptoms. Both require rapid evaluation because early treatment can reduce disability and recurrent risk.

Professor Zhao has contributed to major stroke studies, including research on precision antiplatelet therapy after minor stroke and TIA.

Restarting Antithrombotic Treatment

After a brain hemorrhage, restarting antiplatelet or anticoagulant medicine requires balancing recurrent bleeding against ischemic stroke, heart attack, or embolism.

The decision depends on the original reason for treatment, hemorrhage location and cause, blood-pressure control, MRI markers, heart rhythm, vascular disease, and time since bleeding. Patients should never restart or stop these medicines without their treating team.

Neurocritical Care

Severe stroke can affect breathing, swallowing, blood pressure, brain pressure, temperature, heart rhythm, and multiple organs. Neurocritical care combines neurological monitoring with intensive medical support and early complication prevention.

Families may need structured discussions about prognosis, treatment goals, rehabilitation potential, and uncertainty. Early predictions can change as swelling resolves and sedation is reduced.

Dizziness and Neuro-Otology

Dizziness can result from inner-ear disease, migraine, blood-pressure change, medication, anxiety, or brain and vascular disorders. Sudden persistent vertigo with inability to walk, double vision, weakness, numbness, or severe headache may indicate posterior-circulation stroke.

Assessment can include eye-movement examination, hearing and vestibular tests, MRI, and vascular imaging. A normal early scan does not exclude every posterior-circulation stroke.

Secondary Prevention

Prevention should address the mechanism of the event and may include blood-pressure control, cholesterol treatment, diabetes management, smoking cessation, antiplatelet or anticoagulant therapy, sleep-apnea care, and selected vascular procedures.

Who May Consider a Consultation?

  • stable patients recovering from intracerebral hemorrhage;
  • patients with an uncertain cause of brain bleeding;
  • patients needing review of antiplatelet or anticoagulant decisions;
  • patients with recurrent ischemic stroke or TIA;
  • patients with severe stroke requiring neurocritical-care review;
  • patients with persistent unexplained vertigo or suspected posterior-circulation disease;
  • families seeking prognosis and rehabilitation guidance; or
  • patients seeking a second opinion on stroke prevention.

Medical Records to Prepare

  • a precise symptom-onset and emergency-treatment timeline;
  • brain CT and MRI in original DICOM format;
  • CTA, MRA, catheter angiography, and venous imaging when relevant;
  • intensive-care, neurosurgical, and rehabilitation records;
  • ECGs, prolonged rhythm monitoring, and echocardiography;
  • blood pressure, cholesterol, glucose, kidney, liver, blood-count, inflammatory, and coagulation results;
  • vestibular, hearing, and eye-movement assessments for dizziness;
  • all antiplatelet, anticoagulant, and blood-pressure medicines with dates;
  • current neurological and functional assessments; and
  • a clear list of prevention and recovery goals.

Planning an International Consultation

Any new stroke symptom, sudden severe headache, seizure, confusion, or reduced consciousness requires immediate local emergency care. International travel must not delay treatment.

Stable patients should confirm whether original imaging and intensive-care records can be reviewed. Remote medical-record review requires physician authorization. Final treatment recommendations may require in-person neurological, vestibular, cardiac, and vascular assessment.

How CMCS Can Assist

CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. We assist international patients with organizing and translating stroke records, identifying an appropriate specialist, requesting appointment availability, arranging interpretation, and planning medical travel in China.

Access to Professor Zhao, remote review, admission, testing, or a particular treatment is subject to doctor and hospital approval. CMCS does not guarantee appointments, treatment eligibility, prognosis, or clinical outcomes.

Important Note

Doctor titles, clinical roles, testing, medicines, and appointment arrangements may change. This profile is based on the supplied verified research document and is for general information only. It does not replace assessment by a qualified vascular neurology team.

0 commentaire

Laisser un commentaire